Albert Chenevier hospital
Créteil, Creteil, 94010, France
NCT Number: NCT05944172
Impact of attention on obsessive through the THOUGHT-scale (Troublesome Human Obsessions and Untargeted General Habitual Thoughts Scale): a description of the content of thoughts according to the level of attention demanded by the environment in patients with obsessive disorder compulsive disorder (OCD) and patients without OCD" Validation of THOUGHTS.
Looking for future studies?
Notify Me15 year and older
All sexes
Observational
Créteil, Creteil, 94010, France
We developed a scale (the THOUGHTS) dedicated to allow a subject to subjectively measure its level of mind wandering/daydreaming (and obsessions in case of OCD patients) during different everyday situations. This scale is developed for 15 years old or older students (high school, university). Indeed, common point in everyday life was easier to find in students than in workers where lifestyle can be very divergent according to the job type. Through this scale, we will first detect the situations the more associated with mind wandering/daydreaming in healthy subjects. To do that, we will first find the 50% and the 25% of the situations the most associated with mind wandering. This step will allow us to distinguish two types of situations: situations with high level of mind wandering/daydreaming vs. situations with low level of mind wandering/daydreaming. Then we will do the same analyses in OCD patients to see if situations of high level of mind wandering are the same in both groups. Finally, we will compare the level of obsessions in OCD patients in these two types of situations (linked with high vs. low mind wandering, as defined by healthy subject, OCD patients and both populations).
To make these analyses, we will recruit 40 young OCD people (still students) from only one center, all diagnosed through DSM-5 criteria by a same senior and experimented child and adolescent psychiatrist and 40 matched healthy subjects.
For OCD patients: all comorbidities will be allowed except those associated with hallucinations or delusions: schizophrenia or bipolar disorder will then not be allowed. Neurological disorders will not be allowed too. Y-BOCS or CY-BOCS will be get and analyzed to find if severity could influence our results.
Healthy controls: they will be recruited to be matched with the OCD patients. No psychiatric or neurologic disorder will be allowed. No psychotropic or neurologic treatment will be allowed.
Finally, in terms of statistics, we will use non parametric tests.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
For pathological patients:
For patients who are not affected by the disease:
Exclusion criteria
For pathological patients:
For patients who are free of these conditions:
Time frame: metrics are measured only one time, directly after the subject accept to participate to the study.
demonstrate that in patients with OCD, the level of presence of obsessions is different during active and passive situations, using the THOUGHT questionnaire - scale.
Time frame: measured only one time, directly after the subject accept to participate to the study.
Separated OCD patients in 2 groups according to their YBOCS severity to see if obsessions replace mind wandering in the same manner (the same situation and at the same level)
Assistance Publique - Hôpitaux de Paris
Other
Thoughts Content in OCD: What Links Between Mind Wandering and Obsessions
Acronym: THOUGHTS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06355284
Compulsive Personality Disorder, Mental Disorders
Providence, Rhode Island, United States
View Trial DetailsNCT03182075
Anxiety Disorders, Behavior
Stanford, California, United States
View Trial DetailsNCT03833531
Avoidant Personality Disorder, Compulsive Personality Disorder
Amstelveen, North Holland, Netherlands
View Trial DetailsNCT03495375
ADHD, Aberrant Motor Behavior in Dementia
Frankfurt, Germany
View Trial Details